Olwen Hahn to Soft Tissue Neoplasms
This is a "connection" page, showing publications Olwen Hahn has written about Soft Tissue Neoplasms.
Connection Strength
0.162
-
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. Eur J Cancer. 2019 08; 117:91-98.
Score: 0.162